CCDC167 and breast carcinoma: CCDC167 was reported to be significantly upregulated as a hub gene in the lungs of chloroprene-treated mice (Guo and Xing 2016), and to be downregulated by multiple antitumor therapeutics in breast cancer patients (Chen et al. 2021).